Skip to main content

ExodusPoint Capital Management, LP

Position in DXCM — Dexcom Inc

CIK 1736225 NEW YORK, NY

Position in DXCM

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$19,911,807
+$11,014,644 QoQ
Shares Held
317,067
+136.5% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in DXCM Over Time

Shares Held

Position Value (USD)

Derivatives in DXCM

reported options exposure · as of Sep 30, 2020
CallValue
$515,287
CallShares
5,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Mar 31, 2026

ExodusPoint Capital Management, LP holds $345,630,527 across 29 Medical Devices names. DXCM ranks #3 (5.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 DXCM
Dexcom Inc
This page
317,067 $19,911,807

All Filings in DXCM

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $19,911,807 317,067
2025-12-31 $8,897,163 134,054
2025-09-30 $2,409,924 35,814
2025-06-30 $58,146,138 666,126
2024-12-31 $36,273,016 466,414
2024-09-30 $10,505,168 156,700
2024-06-30 $5,899,501 52,033
2024-03-31 $22,043,313 158,928
2023-12-31 $1,073,502 8,651
2023-09-30 $6,989,942 74,919
2023-03-31 $6,375,958 54,880
2022-12-31 $8,256,781 72,914
2022-09-30 $416,150 5,167
2022-06-30 $9,834,382 131,952
2022-03-31 $1,008,107 7,882
2021-12-31 $1,742,939 12,984
2021-09-30 $1,497,849 10,956
2021-06-30 $420,488 3,939
2020-09-30 $37,615 365
2020-09-30 $515,287 5,000
2020-06-30 $825,799 8,148
2020-03-31 $592,057 8,795